Artemisinin

DB13132InvestigationalSmall molecule

Artemisinin is a medication indicated in the treatment of malaria.

Chemical structure of Artemisinin
Formula / weight
C15H22O5 · 282.336 g/mol (avg)
Code names
NSC-369397

Resolves to

Compound
UNII9RMU91N5K2CAS63968-64-9ChEMBLCHEMBL269671ChEBI223316PubChem68827KEGGC09538
Clinical / RWD
RxNorm2367409ATCP01BE01ATCP01BF07ATCP01BF08PharmGKBPA165111696
Structure
InChIKeyBLUAFEHZUWYNDE-NNWCWBAJSA-NSMILES[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C(=O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Targets
Q08210Dihydroorotate dehydrogenase (quinone), mitochondrial

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
214Drug interactionsStructured to mechanism, not free text
Sign in
16Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
3ATC codesIncluding every combination product, plus 16 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Artemisinin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In